TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins

C1-esterase inhibitor concentrate rescues erythrocytes from complement-mediated destruction in autoimmune hemolytic anemia

(2013) D. Wouters et al.   BLOOD

Cold agglutinin disease

(2013) P. L. Swiecicki et al.   BLOOD

Eculizumab: A Review of Its Use in Atypical Haemolytic Uraemic Syndrome

(2013) Gillian M. Keating   DRUGS

Complement in Immune and Inflammatory Disorders: Pathophysiological Mechanisms

(2013) D. Ricklin et al.   JOURNAL OF IMMUNOLOGY

Complement in Immune and Inflammatory Disorders: Therapeutic Interventions

(2013) D. Ricklin et al.   JOURNAL OF IMMUNOLOGY

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

(2013) C.M. Legendre et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia

(2012) Sigbjørn Berentsen et al.   BLOOD REVIEWS

C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks - final results of the I.M.P.A.C.T.2 study

(2011) T. J. Craig et al.   ALLERGY

How I manage cold agglutinin disease

(2011) Sigbjørn Berentsen   BRITISH JOURNAL OF HAEMATOLOGY

Achievements and Limitations of Complement Inhibition by Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: The Role of Complement Component 3

(2011) A. M. Risitano et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Classification and therapeutic approaches in autoimmune hemolytic anemia: an update

(2011) Marc Michel   Expert Review of Hematology

High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease

(2010) S. Berentsen et al.   BLOOD

A novel approach to preventing the hemolysis of paroxysmal nocturnal hemoglobinuria: both complement-mediated cytolysis and C3 deposition are blocked by a monoclonal antibody specific for the alternative pathway of complement

(2010) M. A. Lindorfer et al.   BLOOD

Heating up cold agglutinins

(2010) M. J. Stone   BLOOD

Clinical immunology of chronic cold agglutinin disease

(2010) Elling Ulvestad et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease

(2009) A. Roth et al.   BLOOD

Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab

(2009) A. M. Risitano et al.   BLOOD

The complement system in systemic autoimmune disease

(2009) Min Chen et al.   JOURNAL OF AUTOIMMUNITY

FDA Report: Eculizumab (Soliris(R)) for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria

(2008) A. Dmytrijuk et al.   ONCOLOGIST